CAR-T and Other Cell Therapy Testingwebmaster2020-01-02T13:22:29+00:00
Chimeric Antigen Receptor T-cell Therapy, CAR-T, is a type of cancer immunotherapy that has gained world-wide interest in recent years, especially after FDA approval of CAR-T treatments for B-cell acute lymphoblastic leukemia and large B-cell non-Hodgkin’s lymphoma. To ensure the safety of the CAR-T treatment, regulatory agencies require thorough characterization of the manufactured CAR T-Cells. In addition, during the clinical trial or patient treatment phase, the level of modified T-cells in patients’ blood must be monitored frequently in a timely manner.
Regulatory agencies require Sponsors of CAR / TCR therapies to determine the copy number of the inserted genes in manufactured T-cells before releasing for clinical use. Avance Biosciences’ team has more than two decades of experience in the design, validation, and execution of hundreds of QPCR copy number analysis projects in compliance with CGMP regulations.
In vivo toxicity and shedding studies are sometimes required by regulatory agencies to evaluate the safety of therapeutic cells. Avance Biosciences offers GLP compliant QPCR, ddPCR, and NGS amplicon sequencing services to accurately assess the quantity of therapeutic cells in animal blood, CFS, and tissues for biodistribution studies.
Avance Biosciences can help our clients to design and execute custom assays to determine gene insertion sites. We use a combination of NGS, PCR, and Sanger sequencing methods to delineate and validate potential insertion junctions and their locations in host genome.
Lentivirus is commonly used to generate CAR-T cells due to its ability to insert genes into host genome. It is critical to ensure that there is no replication competent lentivirus (RCL) in the therapeutic cells. Avance Biosciences provides fast turn-around RCL testing services using qPCR and ddPCR methods.
Avance Biosciences is experienced in supporting our clients for pharmacokinetics study of mRNA or miRNA in animal tissues and in human blood. Our study directors and lab analysts are proficient in qPCR and ddPCR assay design and validation, for both relative and absolute quantification of RNAs.
Avance Biosciences is experienced in the monitoring, evaluation and quantitation of RNA in animal tissues or in human blood to support our clients’ pharmacokinetic studies. Our study directors and lab analysts are proficient in QPCR assay design and validation, for both relative and absolute quantification of RNAs.
We are dedicated to timely, high-quality service from the start of your project to the finish. Send us a note or give us a call to find out what Avance can do for you.
From the preliminary conclusion of this work, we are already pleased to thank you for your customer-oriented approach and proactive communication in the course of this study. We are happy to see the profound difference in business mindset between your organization and our previous vendor…
Project Manager, Belgium
Thank you so much for successfully completing this important project for us on time. We are very satisfied with the final report and thank you for taking the extra effort to customize the report format. We will definitely use your lab for future projects.
Program Manager, California
It has been a pleasure working with you and your team. The project was carried out to the highest standard and delivered in a timely manner. I will definitely recommend Avance Biosciences’ services to colleagues and friends.
Senior Scientist, Singapore
When you partner with Avance Biosciences, we give you undivided attention, share our experience and knowledge, and respond to your needs in a timely manner. Contact our technical staff to discuss how we can support you in your project!
Dedication to Quality
The Avance Biosciences team is committed to strict adherence to cGMP and GLP regulations enacted by the US, European, Japanese, and other international regulatory agencies.
Our team has extensive knowledge and experience working with scientists, QA/QC professionals, and project managers from over 100 pharmaceutical and biotechnology companies and organizations throughout the world.
Transparency and integrity are two of our core values. Our well-trained, friendly, and professional study directors and project managers strive to complete your projects on-time with open communication channels and to your specifications.
Avance Biosciences’ cGMP/GLP compliant genomic and microbial assays make use of the advanced technologies including real-time PCR, ddPCR, Sanger sequencing, next-gen sequencing, Southern blot, and more.